Matthew Heidinger
About Matthew Heidinger
Matthew Heidinger is a Project Analyst in Cell Therapy Strategic Sourcing at Bristol Myers Squibb, with previous experience in clinical cell processing at Novartis.
Title
Matthew Heidinger serves as Project Analyst, Cell Therapy Strategic Sourcing at Bristol Myers Squibb. He assumed this position in October 2020.
Current Company
Matthew Heidinger is currently employed by Bristol Myers Squibb, where he works as a Project Analyst in the Cell Therapy Strategic Sourcing division. He started his tenure with the company in October 2020.
Previous Roles at Novartis
Matthew Heidinger has a diverse clinical cell processing background from his tenure at Novartis. His roles included Supervisor, Clinical Cell Processing in 2020 for three months, Senior Clinical Cell Processing Specialist from 2019 to 2020 for seven months, Clinical Cell Processing Specialist from 2018 to 2019 for one year, and Assistant Scientist Intern for three months in 2018. All positions were based in East Hanover, New Jersey.
Education and Expertise
Matthew Heidinger holds a Master of Business and Science in Drug Discovery and Development from Rutgers University, completed in 2021. He also earned a Bachelor of Arts in Biology/Biological Sciences from the same institution in 2018. His educational background complements his professional experience in clinical cell processing and strategic sourcing.
Experience in Clinical Cell Processing
Matthew Heidinger has a robust background in clinical cell processing, having worked in multiple related roles at Novartis from 2018 to 2020. His experience spans across various positions including Clinical Cell Processing Specialist and Senior Clinical Cell Processing Specialist, equipping him with in-depth knowledge and skills in the field.